首页> 外文会议>Conference on image perception, observer performance, and technology assessment >Evaluation of Correlation between CT Image Features and ERCC1 Protein Expression in Assessing Lung Cancer Prognosis
【24h】

Evaluation of Correlation between CT Image Features and ERCC1 Protein Expression in Assessing Lung Cancer Prognosis

机译:CT图像特征与ERCC1蛋白表达在肺癌预后评估中的相关性评价

获取原文

摘要

Stage Ⅰ non-small-cell lung cancers (NSCLC) usually have favorable prognosis. However, high percentage of NSCLC patients have cancer relapse after surgery. Accurately predicting cancer prognosis is important to optimally treat and manage the patients to minimize the risk of cancer relapse. Studies have shown that an excision repair cross-complementing 1 (ERCC1) gene was a potentially useful genetic biomarker to predict prognosis of NSCLC patients. Meanwhile, studies also found that chronic obstructive pulmonary disease (COPD) was highly associated with lung cancer prognosis. In this study, we investigated and evaluated the correlations between COPD image features and ERCC1 gene expression. A database involving 106 NSCLC patients was used. Each patient had a thoracic CT examination and ERCC1 genetic test. We applied a computer-aided detection scheme to segment and quantify COPD image features. A logistic regression method and a multilayer perceptron network were applied to analyze the correlation between the computed COPD image features and ERCC1 protein expression. A multilayer perceptron network (MPN) was also developed to test performance of using COPD-related image features to predict ERCC1 protein expression. A nine feature based logistic regression analysis showed the average COPD feature values in the low and high ERCC1 protein expression groups are significantly different (p < 0.01). Using a five-fold cross validation method, the MPN yielded an area under ROC curve (AUC = 0.669±0.053) in classifying between the low and high ERCC1 expression cases. The study indicates that CT phenotype features are associated with the genetic tests, which may provide supplementary information to help improve accuracy in assessing prognosis of NSCLC patients.
机译:Ⅰ期非小细胞肺癌(NSCLC)通常具有良好的预后。但是,非小细胞肺癌患者中有很高的比例在手术后复发。准确地预测癌症的预后对于优化治疗和管理患者以最小化癌症复发的风险非常重要。研究表明,切除修复交叉互补1(ERCC1)基因是预测NSCLC患者预后的潜在有用的遗传生物标记。同时,研究还发现,慢性阻塞性肺疾病(COPD)与肺癌的预后高度相关。在这项研究中,我们调查和评估了COPD图像特征与ERCC1基因表达之间的相关性。使用了涉及106名NSCLC患者的数据库。每位患者均进行了胸部CT检查和ERCC1基因检测。我们应用了计算机辅助检测方案来分割和量化COPD图像特征。应用逻辑回归方法和多层感知器网络分析了COPD图像特征与ERCC1蛋白表达之间的相关性。还开发了多层感知器网络(MPN),以测试使用COPD相关图像特征预测ERCC1蛋白表达的性能。基于九个特征的逻辑回归分析表明,低和高ERCC1蛋白表达组的平均COPD特征值存在显着差异(p <0.01)。使用五重交叉验证方法,在对低和高ERCC1表达病例进行分类时,MPN产生了ROC曲线下的面积(AUC = 0.669±0.053)。该研究表明,CT表型特征与基因检测有关,这可能提供补充信息,以帮助提高评估NSCLC患者预后的准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号